Eloranta JJ - Search Results

1

Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients.

Wojtal KA, Eloranta JJ, Hruz P, Gutmann H, Drewe J, Staumann A, Beglinger C, Fried M, Kullak-Ublick GA, Vavricka SR. Wojtal KA, et al. Among authors: eloranta jj. Drug Metab Dispos. 2009 Sep;37(9):1871-7. doi: 10.1124/dmd.109.027367. Epub 2009 Jun 1. Drug Metab Dispos. 2009. PMID: 19487253 Free article.

2

Regional distribution of solute carrier mRNA expression along the human intestinal tract.

Meier Y, Eloranta JJ, Darimont J, Ismair MG, Hiller C, Fried M, Kullak-Ublick GA, Vavricka SR. Meier Y, et al. Among authors: eloranta jj. Drug Metab Dispos. 2007 Apr;35(4):590-4. doi: 10.1124/dmd.106.013342. Epub 2007 Jan 12. Drug Metab Dispos. 2007. PMID: 17220238

3

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism.

Eloranta JJ, Kullak-Ublick GA. Eloranta JJ, et al. Arch Biochem Biophys. 2005 Jan 15;433(2):397-412. doi: 10.1016/j.abb.2004.09.019. Arch Biochem Biophys. 2005. PMID: 15581596 Review.

4

The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism.

Eloranta JJ, Jung D, Kullak-Ublick GA. Eloranta JJ, et al. Mol Endocrinol. 2006 Jan;20(1):65-79. doi: 10.1210/me.2005-0159. Epub 2005 Aug 25. Mol Endocrinol. 2006. PMID: 16123152

5

The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.

Landrier JF, Eloranta JJ, Vavricka SR, Kullak-Ublick GA. Landrier JF, et al. Among authors: eloranta jj. Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G476-85. doi: 10.1152/ajpgi.00430.2005. Epub 2005 Nov 3. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16269519 Free article.

6

Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.

Zaïr ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA. Zaïr ZM, et al. Among authors: eloranta jj. Pharmacogenomics. 2008 May;9(5):597-624. doi: 10.2217/14622416.9.5.597. Pharmacogenomics. 2008. PMID: 18466105 Free article. Review.

7

The role of FXR in disorders of bile acid homeostasis.

Eloranta JJ, Kullak-Ublick GA. Eloranta JJ, et al. Physiology (Bethesda). 2008 Oct;23:286-95. doi: 10.1152/physiol.00020.2008. Physiology (Bethesda). 2008. PMID: 18927204 Free article. Review.

8

Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression.

Klein K, Kullak-Ublick GA, Wagner M, Trauner M, Eloranta JJ. Klein K, et al. Among authors: eloranta jj. Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G936-47. doi: 10.1152/ajpgi.90678.2008. Epub 2009 Feb 19. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19228884 Free article.

9

Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.

Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka SR, Fried M, Kullak-Ublick GA; Swiss IBD Cohort Study Group. Eloranta JJ, et al. Pharmacogenet Genomics. 2011 Sep;21(9):559-64. doi: 10.1097/FPC.0b013e328348f70c. Pharmacogenet Genomics. 2011. PMID: 21832969 Free article.

10

Fc gamma receptor CD64 modulates the inhibitory activity of infliximab.

Wojtal KA, Rogler G, Scharl M, Biedermann L, Frei P, Fried M, Weber A, Eloranta JJ, Kullak-Ublick GA, Vavricka SR. Wojtal KA, et al. Among authors: eloranta jj. PLoS One. 2012;7(8):e43361. doi: 10.1371/journal.pone.0043361. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22937039 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters